Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life StudyAndrea Picchianti Diamanti, Annamaria Iagnocco, G. Crepaldi et al.|Rheumatology and Therapy|2024Cited by 11
OP0223 DEVELOPMENT AND PRELIMINARY VALIDATION OF ULTRASONOGRAPHIC DISEASE ACTIVITY AND DAMAGE SCORES IN PSORIATIC ARTHRITIS PATIENTS: RESULTS FROM THE UPSTREAM (ULTRASOUND IN PSORIATIC ARTHRITIS TREATMENT) STUDYAlen Zabotti, Annamaria Iagnocco, Matteo Piga et al.|Annals of the Rheumatic Diseases|2021Cited by 2
Clinical and ultrasound remission at 48 weeks of upadacitinib in rheumatoid arthritis: real-world results from the Italian multicenter UPARAREMUS studyAndrea Picchianti Diamanti, Annamaria Iagnocco, Valentino Paci et al.|Arthritis Research & Therapy|2025Cited by 1
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of RheumatologyAlen Zabotti, Barbara Gabrielli, Matteo Piga et al.|Annals of the Rheumatic Diseases|2025Cited by 1
AB0526 CLINICAL AND ULTRASONOGRAPHIC REMISSION IN BIO-NAÏVE AND BIO-FAILURE RHEUMATOID ARTHRITIS PATIENTS AT 24-WEEK OF UPADACITINIB TREATMENT: THE UPARAREMUS REAL-LIFE STUDYAnnamaria Iagnocco, Maria Sofia Cattaruzza, Roberta Rosa et al.|Annals of the Rheumatic Diseases|2024Cited by 0